It is currently clear that the oxidized purine and pyrimidine nucleotides (DNA oxidative damage) are ubiquitously present in the BM CD34+ cells of patients with MDS when compared with controls [170], and enhanced ROS levels and oxidative damage markers are also commonly detected. Here, CD34 is linked to myelodysplastic syndrome.